ArticleJournal of immunology research2015

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.

Tobias Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.